Terlipressin Squeaks by FDA Review for Hepatorenal Syndrome 1
The US Food and Drug Administration's (FDA's) Cardiovascular and Renal Drugs Advisory Committee narrowly recommended, by an 8-7 vote, that the agency grant marketing approval to terlipressin for the treatment…
